SYNAGEVA BIOPHARMA CORP's ticker is GEVA and the CUSIP is 87159A103. A total of 97 filers reported holding SYNAGEVA BIOPHARMA CORP in Q3 2013. The put-call ratio across all filers is 0.10 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2015 | $4,974,000 | +12.6% | 51,000 | +7.1% | 0.01% | +25.0% |
| Q4 2014 | $4,417,000 | +34.6% | 47,600 | -0.2% | 0.00% | +33.3% |
| Q3 2014 | $3,281,000 | -37.3% | 47,700 | -4.4% | 0.00% | -40.0% |
| Q2 2014 | $5,230,000 | +15.2% | 49,900 | -8.8% | 0.01% | 0.0% |
| Q1 2014 | $4,539,000 | +15.9% | 54,709 | -9.6% | 0.01% | +25.0% |
| Q4 2013 | $3,915,000 | -2.2% | 60,500 | -4.3% | 0.00% | -20.0% |
| Q3 2013 | $4,002,000 | +69.2% | 63,200 | +12.3% | 0.01% | +66.7% |
| Q2 2013 | $2,365,000 | – | 56,300 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|